Blinatumomab vs Chemotherapy among Children with Relapsed Acute Lymphoblastic Leukemia - Reply

Franco Locatelli; Gerhard Zugmaier; Arend Von Stackelberg

doi:10.1001/jama.2021.8154

Blinatumomab vs Chemotherapy among Children with Relapsed Acute Lymphoblastic Leukemia - Reply

Franco Locatelli, Gerhard Zugmaier, Arend Von Stackelberg

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	359-360
Numero di pagine	2
Rivista	JAMA
Volume	326
DOI	https://doi.org/10.1001/jama.2021.8154
Stato di pubblicazione	Pubblicato - 2021

Keywords

BLINATUMOMAB

Accesso al documento

10.1001/jama.2021.8154

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{e765bf78267b41e59457619adc9a454c,

title = "Blinatumomab vs Chemotherapy among Children with Relapsed Acute Lymphoblastic Leukemia - Reply",

keywords = "BLINATUMOMAB, BLINATUMOMAB",

author = "Franco Locatelli and Gerhard Zugmaier and {Von Stackelberg}, Arend",

year = "2021",

doi = "10.1001/jama.2021.8154",

language = "English",

volume = "326",

pages = "359--360",

journal = "JAMA",

issn = "0098-7484",

publisher = "American Medical Association:515 North State Street:Chicago, IL 60610:(800)262-2350, (312)464-2518, EMAIL: [email protected], INTERNET: http://www.ama-assn.org, Fax: (312)464-5600",

}

TY - JOUR

T1 - Blinatumomab vs Chemotherapy among Children with Relapsed Acute Lymphoblastic Leukemia - Reply

AU - Locatelli, Franco

AU - Zugmaier, Gerhard

AU - Von Stackelberg, Arend

PY - 2021

Y1 - 2021

KW - BLINATUMOMAB

UR - http://hdl.handle.net/10807/229513

U2 - 10.1001/jama.2021.8154

DO - 10.1001/jama.2021.8154

M3 - Article

SN - 0098-7484

VL - 326

SP - 359

EP - 360

JO - JAMA

JF - JAMA

ER -